Good morning
@awichiuFrom the latest conference call Now after 3 years of R&D, we were very pleased to launch SleepCheck on the App Store on June 29. SleepCheck is the world's first and only regulatory approved and clinically validated direct-to-consumer sleep apnea screening app. One in 5 Australian adults may be affected by sleep apnea and up to 80% of those do not know that they have it. SleepCheck is targeted as a mass market direct-to-consumer app. And so our marketing message and strategy is especially important. We've been working closely with the creative team with Isobar in Sydney to create an engaging campaign around snoring and sleep apnea. Isobar, a leading digital marketing agency, who worked with some of Australia's most prestigious businesses and brands. We're all looking forward to next week's launch of that campaign. Based on our product road map and early customer feedback, we have product improvements in the pipeline and we'll release an update for SleepCheck next week. This includes the translation of SleepCheck into 5 European languages, and so we'll be broadening the availability of SleepCheck into additional countries in Europe and Asia.
We're also working to have SleepCheck available in the U.S. and plan to file a pre-submission meeting request with the FDA in August. As well we've been working on making SleepCheck and ResAppDx available on Android devices. Android is a tricky platform to work with many different hardware devices being used. These different devices have different microphones, and we need to be 100% confident that these microphones behave in the correct ways. And importantly, our algorithms perform as expected. We now have a comprehensive bench testing protocol and are working through various make and models of Android phones. We hope to have products available on an initial set of Android phones later this year. Overall, we are very pleased with the progress that we've made in the last quarter, with our first commercial deals completed with telehealth companies and SleepCheck being released on the App Store. The initial response from the market for this product has been very positive, and we look forward to continuing to see the use of these products grow. There are many complex parts to ResApp business now with multiple products and multiple channels to market. In the long term, we're focused on getting our products into the hands of consumers to help them better manage their health. Empowering telehealth to bring convenient but also high-quality health care to all and helping identify common but underdiagnosed diseases, such as sleep apnea at scale in very large populations.
Regards
Bloky